Literature DB >> 19033180

Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany.

Christian Gingter1, Stefan Wilm, Heinz-Harald Abholz.   

Abstract

BACKGROUND: According to literature, COPD rates are high in spite of decreasing rates of main risk factors smoking and air pollution in developed countries. general practice is a good place to survey unbiased prevalence rates. Ten studies done in general practice over the last 20 years found prevalence rates among smokers between 13.1% and 92.1%.
OBJECTIVE: Prevalence and detection rates of COPD in smokers in German general practice.
METHODS: Twenty-eight of 34 invited and eligible GP surgeries in/around Duesseldorf, Germany, took part in the non-announced 2-day investigation of all smokers (> or =40 years) who visited the surgeries. Lung function test by hand-held spirometer, peak flow, sympton part of St George's Respiratory Questionnaire, and data on smoking habits were used. GOLD criteria for COPD were employed. GPs had to give their diagnosis not knowing the test results.
RESULTS: Of 3157 patients attending the 28 surgeries, 538 were smokers. Four hundred and thirty-seven of these agreed to participate, 5 had to be excluded for medical reasons/unacceptable spirometry. Three hundred and ninety-eight patients have not been previously diagnosed with COPD or asthma. Thirty patients were disgnosed with COPD, making a prevalence of 6.9%, of which 15 patients were already known as having COPD.
CONCLUSION: Our result of low prevalence differs strongly from all other studies in general practice. Considering our study design which avoids selection bias found in nearly all other studies (no pre-announcement, no self-selection of patients or GPs, high participation rate and testing all patients), we strongly believe that our findings reflect the current situation of COPD in German general practice.

Entities:  

Mesh:

Year:  2008        PMID: 19033180     DOI: 10.1093/fampra/cmn084

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  13 in total

Review 1.  The diagnosis of chronic obstructive pulmonary disease.

Authors:  Rainer Burkhardt; Wulf Pankow
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

2.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

3.  Burden of obstructive lung disease study in tehran: research design and lung spirometry protocol.

Authors:  Hooman Sharifi; Mohammad Reza Masjedi; Habib Emami; Mostafa Ghanei; Sonia Buist
Journal:  Int J Prev Med       Date:  2014-11

4.  Interim Report from Burden of Obstructive Lung Disease (BOLD Study) in Tehran: Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease.

Authors:  Hooman Sharifi; Mohammad Reza Masjedi; Habib Emami; Mostafa Ghanei; Alireza Eslaminejad; Golnar Radmand; A Sonia Buist
Journal:  Tanaffos       Date:  2014

5.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

Review 6.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

7.  Impact of risk factors, activities and psychological disorders on the health of patients with chronic obstructive pulmonary disease in China: a cross-sectional study.

Authors:  Lei Zhang; Peian Lou; Yanan Zhu; Peipei Chen; Pan Zhang; Jiaxi Yu; Ning Zhang; Na Chen; Hongmin Wu; Jing Zhao
Journal:  BMC Public Health       Date:  2013-07-02       Impact factor: 3.295

8.  Sample survey of chronic obstructive pulmonary disease and associated risk factors in isfahan, iran.

Authors:  Mohammad Golshan; Babak Amra; Tobias Welte
Journal:  Tanaffos       Date:  2011

9.  TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.

Authors:  Rachel E Jordan; Peymané Adab; Sue Jowett; Jen L Marsh; Richard D Riley; Alexandra Enocson; Martin R Miller; Brendan G Cooper; Alice M Turner; Jon G Ayres; Kar Keung Cheng; Kate Jolly; Robert A Stockley; Sheila Greenfield; Stanley Siebert; Amanda Daley; David A Fitzmaurice
Journal:  BMC Pulm Med       Date:  2014-10-04       Impact factor: 3.317

10.  Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease.

Authors:  Hooman Sharifi; Mohammad Reza Masjedi; Habib Emami; Mostafa Ghanei; Alireza Eslaminejad; Golnar Radmand; Sonia Buist
Journal:  Lung India       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.